11th Annual Hematology and Medical Oncology Board Review: Contemporary Practice

Friday, March 10, 2023, 9:00 AM - Monday, March 13, 2023, 1:00 PM, Online


This four day course will provide an up-to-date and comprehensive review of the diagnosis, staging, and management of neoplastic disease, including solid tumor and hematologic oncology. Lectures will focus on disease specific topics in gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, as well as hematologic oncology. Who Should Attend The target audience for this program is medical oncology professionals, including physicians, nurses, pharmacists, fellows and residents. Live Virtual Format This live virtual program will be delivered using Zoom. We encourage all attendees to download the Zoom app prior to the start of the course (zoom.us/download). CME credit and ABIM MOC points will be offered for this live virtual program. Detailed access and credit instructions will be emailed to attendees prior to the start of the course. Course registration includes access to an online syllabus, which includes PDFs of the slides and recorded videos of the faculty presentations.

1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
3. Prepare for ABIM examinations in medical oncology and hematology.

Virtual Registration Fees

• Physicians (MDs, PhDs, and DOs): $1,650
• Residents, Fellows, Nurses, and Other Healthcare Providers: $1,075
• Industry Professionals*: $2,885

*Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Discounts/Promotions/Complimentary Registration 

• A 30% registration discount is available for MSK Alumni and MSK Cancer Alliance members to attend a MSK CME course. If you are a member of one of these groups, please contact [email protected] for details. Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.
• Registration is complimentary for all MSK employees; however, you must complete registration in order to attend this course. If you are registered for this course and are unable to attend, please email [email protected]. 
• A limited number of complimentary registration spots for the 2023 HemOnc Board Review are available for MSK International Observers as well as graduate students and practicing oncologists in India. Interested providers who are part of these two international groups must apply for consideration, please email [email protected]. Approved applicants will be notified of their acceptance of complimentary registration by March 1, 2023.

Cancellation Policy

If you wish to cancel your participation in this course, you must email [email protected] at least seven (7) days prior to the start of the course, and your refund will be subject to a $25 administrative fee. Cancellations or no-shows within seven (7) days of the course are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event we must cancel or postpone this course, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 30.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 30.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MSK Course Directors 

David H. Ilson, MD, PhD, FACP, FASCO
Attending Physician, Member, Gastrointestinal Oncology Service
Professor of Medicine, Weill Cornell Medical College

Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care
Associate Attending, Lymphoma Service 
Associate Professor of Medicine, Weill Cornell Medical College

 

MSK Course Faculty

Ghassan K. Abou-Alfa, MD, MBA
Attending Physician, Gastrointestinal Oncology Service

Carol Aghajanian, MD
Attending Physician, Chief, Gynecologic Medical Oncology Service

Lior Z. Braunstein, MD
Assistant Attending Radiation Oncologist, External Beam Radiotherapy Service

Andrea Cercek, MD
Section Head, Colorectal Cancer; 
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers; 
Associate Attending Physician, Gastrointestinal Oncology Service

Paul B. Chapman, MD
Attending Physician, Melanoma Service

Noura J. Choudhury, MD
Assistant Attending Physician, Thoracic Oncology Service & Early Drug Development Service

Hiram S. Cody III, MD, FACS
Attending Surgeon, Breast Service;
Professor of Surgery, Weill Cornell Medical College

Chau T. Dang, MD
Regional Care Network Medical Site Director, MSK Westchester;
Attending Physician, Breast Medicine Service

Mark A. Dickson, MD
Associate Attending Physician, Sarcoma Medical Oncology Service

Lara A. Dunn, MD
Assistant Attending Physician, Head and Neck Oncology Service

Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service; 
Associate Professor of Medicine, Weill Cornell Medical College

Devika Gajiria, MD
Assistant Attending Physician, Breast Medicine Service

Mark B. Geyer, MD
Adolescent and Young Adult Program Leader;
Assistant Attending, Leukemia Service & Cellular Therapy Service;
Assistant Professor of Medicine, Weill Cornell Medicine

Mrinal M. Gounder, MD
Associate Attending Physician, Sarcoma Medical Oncology & Early Drug Development (Phase I);
Physician Ambassador, India and Asia, Bobst International Center, MSK

Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician, Gynecologic Medical Oncology Service

Malin Hultcrantz, MD
Assistant Attending Physician, Myeloma Service;
Assistant Professor of Medicine, Weill Cornell Medicine

Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service & Early Drug Development Service 

Thomas J. Kaley, MD
Vice Chair, Department of Neurology; 
Associate Attending Neuro-Oncologist

Simon Mantha, MD, MPH
Attending Physician, Hematology Service

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program;
Attending Physician, Leukemia Service

Jodi V. Mones, MD
Associate Fellowship Program Director;
Associate Attending Physician, Hematology Service

Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service

Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service

Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology;
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research;
Section Head, Hepatopancreaticobilary & Neuroendocrine Cancers;
Attending Physician, Member, Gastrointestinal Oncology Service;
Professor of Medicine, Weill Cornell Medical College

Rekha Parameswaran, MD
Attending Physician, Hematology Service

Gregory J. Riely, MD, PhD
Vice Chair, Clinical Research; 
Attending Physician, Thoracic Oncology Service 

Lindsey Roeker, MD
Assistant Attending Physician, Leukemia Service

Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service;
Professor of Medicine, Weill Cornell Medical Center

Rachel Sanford, MD
Assistant Attending Physician, Breast Medicine Service

Michael Scordo, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service

Susan K. Seo, MD
Director, Antibiotic Management Program; 
Attending Physician, Infectious Disease Service 

Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service

Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs;
Attending Physician, Genitourinary Oncology Service & Cellular Therapy Service

Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service & Gastrointestinal Oncology Service

Eytan M. Stein, MD
Chief, Leukemia Service;
Director, Program for Drug Development in Leukemia 

Anna M. Varghese, MD
Assistant Attending Physician, Gastrointestinal Oncology Service

Cy R. Wilkins, MD
Assistant Attending Physician, Hematology Service;
Assistant Professor of Clinical Medicine, Weill Cornell Medical College

Marjorie G. Zauderer, MD
Co-Director MSK Mesothelioma Program; 
Associate Attending Physician, Thoracic Oncology Service

Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.